Cargando…
Development and Evaluation of Inhalational Liposomal System of Budesonide for Better Management of Asthma
Budesonide is a corticosteroid used by inhalation in the prophylactic management of asthma. However, frequent dosing and adverse effects (local and systemic) remain a major concern in the use of budesonide. Liposomal systems for sustained pulmonary drug delivery have been particularly attractive bec...
Autores principales: | Parmar, J. J., Singh, D. J., Hegde, Darshana D., Lohade, A. A., Soni, P. S., Samad, A., Menon, Mala D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013572/ https://www.ncbi.nlm.nih.gov/pubmed/21218054 http://dx.doi.org/10.4103/0250-474X.73916 |
Ejemplares similares
-
Inhalational System for Etoposide Liposomes: Formulation Development and In Vitro Deposition
por: Parmar, J. J., et al.
Publicado: (2011) -
Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer
por: Singh, D. J., et al.
Publicado: (2012) -
Efficacy of inhaled budesonide for the treatment of severe equine asthma
por: Lavoie, J. P., et al.
Publicado: (2018) -
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006) -
Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
por: Arun, Jenish J, et al.
Publicado: (2012)